Sho Kobayashi
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Biochemistry top 2%
- Oncology
- Co-authors
- Junichi FujiiTakujiro HommaHideyo SatoMarcus ConradShiro BannaiMami SatoRyosuke KusumiT. Izumikawa
- Topics
- Ferroptosis and cancer prognosis (12 papers)Sulfur Compounds in Biology (10 papers)Amino Acid Enzymes and Metabolism (9 papers)
- Partner nations
- JapanGermanySouth Korea
In The Last Decade
Sho Kobayashi
39 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Biology 699
- Pulmonary and Respiratory Medicine 573
- Cancer Research 430
- Biochemistry 185
- Oncology 123
Countries citing papers authored by Sho Kobayashi
This map shows the geographic impact of Sho Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Kobayashi more than expected).
Fields of papers citing papers by Sho Kobayashi
This network shows the impact of papers produced by Sho Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Kobayashi. The network helps show where Sho Kobayashi may publish in the future.
Co-authorship network of co-authors of Sho Kobayashi
This figure shows the co-authorship network connecting the top 25 collaborators of Sho Kobayashi. A scholar is included among the top collaborators of Sho Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Kobayashi. Sho Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 48 | |
| 5 | 27 | |
| 6 | 11 | |
| 7 | 40 | |
| 8 | 37 | |
| 9 | 11 | |
| 10 | 11 | |
| 11 | 12 | |
| 12 | 90 | |
| 13 | The ferroptosis inducer erastin irreversibly inhibits system xc− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cellsbreakdown → | 311 |
| 14 | 62 | |
| 15 | 7 | |
| 16 | 16 | |
| 17 | 24 | |
| 18 | 11 | |
| 19 | 73 | |
| 20 | 27 |
About Sho Kobayashi
Sho Kobayashi is a scholar working on Biochemistry, Pharmacology and Cell Biology, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (12 papers), Sulfur Compounds in Biology (10 papers) and Amino Acid Enzymes and Metabolism (9 papers). The work is most often cited by research in Cancer Research (430 citations), Biochemistry (185 citations) and Pulmonary and Respiratory Medicine (573 citations). Sho Kobayashi has collaborated with scholars based in Japan, Germany and South Korea. Frequent co-authors include Junichi Fujii, Takujiro Homma, Hideyo Sato, Marcus Conrad, Shiro Bannai, Mami Sato, Ryosuke Kusumi, T. Izumikawa, Yuhei Komiyama and Satoru Sasaki. Their work appears in journals such as Journal of Biological Chemistry, Brain and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.